Speech Clinical Trial - Modulation of Sensory Acuity With Transcranial

Status Completed

Clinical Trial Summary

The purpose of this research study is to understand how the brain processes and controls speech in healthy people. The investigators are doing this research because it will help identify the mechanisms that allow people to perceive their own speech errors and to learn new speech sounds, which may be applied to people who have communication disorders. 15 participants will be enrolled into this part of the study and can expect to be on study for 4 visits of 2-4 hours each.

Clinical Trial Description

The overall study (Establishing the clinical utility of sensorimotor adaptation for speech rehabilitation) aims to understand how cognitive, perceptual, and motor processes are integrated in the control of speech movements. The investigators study how this complex skill is performed in healthy speakers to understand how this system functions, how this skill relates to the perception of speech, and what role different parts of the brain play in this process. Different studies look at how speech motor control is executed, maintained, and changed. Overall, the study will recruit 329 participants over the course of 5 years. Participants can expect to be on study for up to 3 weeks. The entire study is composed of 8 experiments and 6 interventions. The present record represents the experiments involving transcranial magnetic stimulation (TMS), i.e. Experiment 7: Using TMS to alter somatosensory acuity. This paradigm uses theta-burst transcranial magnetic stimulation (tbTMS) to modulate the excitability of sensory cortices to examine the effect on sensory acuity and sensorimotor adaptation. Participants will complete three total sessions targeting primary somatosensory cortex (S1): one using intermittent theta-burst stimulation (iTBS), one using continuous theta-burst stimulation (cTBS), and one with sham stimulation. The effect of the stimulation on auditory acuity will be measured through a tactile discrimination task in which participants report the relative amplitude and/or timing of vibrating probes pressed lightly into the tongue using a custom device (a version of the Corticalmetrics Brain Gauge adapted to study the orofacial system). ;

Study Design

Related Conditions & MeSH terms

Speech

Clinical Trial Details

NCT number	NCT05723575
Study type	Interventional
Source	University of Wisconsin, Madison
Contact
Status	Completed
Phase	N/A
Start date	November 18, 2022
Completion date	May 26, 2023

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06053190` - Effects of Clear Speech on Listening Effort and Memory in Sentence Processing	N/A
Completed	`NCT04547569` - Somesthesic Role of the Ventro-lateral Prefrontal Cortex in Speech Motor Learning	N/A
Completed	`NCT05286658` - Behavioral and Neural Responses to External Alterations of Speech Variability	N/A
Recruiting	`NCT05634356` - Social Influences on Sensorimotor Integration of Speech Production and Perception During Early Vocal Learning	N/A
Completed	`NCT05635929` - Oral Mucositis and Quality of Life With a Mucosa Topical Composition in Head & Neck Cancer Patients.	N/A
Recruiting	`NCT03504514` - Evaluation of the Effect of a Speech Detection Tool on the Improvement of Phonation in Neuromuscular Patients Dependent on Mechanical Ventilation	N/A
Completed	`NCT04010500` - Speech Performance of Rugby Players When Using Different Types of Mouthguard	N/A
Completed	`NCT05256095` - Thinking in Speech for Children With Autism	N/A
Recruiting	`NCT02753192` - Dysarthria in Parkinson's Disease: Lusophony vs. Francophony Comparison	N/A
Active, not recruiting	`NCT04273672` - Speech, Linguistic and Acoustic Markers in Parkinson's Disease
Recruiting	`NCT06164717` - Behavioral and Neural Characteristics of Adaptive Speech Motor Control	N/A
Completed	`NCT03008174` - Early Speech With One-Way Speaking Valve in Tracheostomy Patients	N/A
Recruiting	`NCT06168695` - Impact of Anterior Cross Bite Treatment on Children's Speech Performance	N/A
Recruiting	`NCT06233513` - Vowel Space Expansion Sensorimotor Adaptation	N/A
Enrolling by invitation	`NCT05876910` - Neural Mechanisms for Stopping Ongoing Speech Production	N/A
Completed	`NCT04690166` - Validation of the Turkish Translation of the London Speech Evaluation Scale
Not yet recruiting	`NCT06234059` - Modulation of Sensory Acuity With Transcranial Magnetic Stimulation (TMS)	N/A
Recruiting	`NCT05954520` - Effects of Nonlinear Signal Processing Algorithms on Speech Perception	N/A
Recruiting	`NCT04818021` - Contribution of the Somatosensory System to Speech Perceptual Processing	N/A
Recruiting	`NCT04818268` - Sensory Memory in Speech Motor Learning	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Modulation of Sensory Acuity With Transcranial Magnetic Stimulation (TMS)

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms